This space represents the ideas, views, opinions, projects and data of researchers within the Aptamer Stream of the Freshman Research Initiative, a program developed at the University of Texas at Austin. These are projects we currently have in the pipeline.
- We're not exclusive...we are SELECTIVE!
Great link Amanda! This is exactly the type of contribution I'd hope for - one that isn't for your project but could be helpful to others in lab.
On a personal note, my father-in-law was one of the trial patients who took Gleevec for his leukemia. He went into remission on it and even trialed the second and third generation Gleevec.
Apparently Gleevec binds gamma-secretase activating protein to reduce plaques caused by beta-amyloid peptide. If anyone wanted to select an aptamer against gamma-secretase activating protein, it could be functionalized with Gleevec working as a treatment for Alzheimer's disease.
I'm particularly interested in this research since my grandfather and step-grandfather suffered from Alzheimer's for a number of years prior to their passing.
2 comments:
Great link Amanda! This is exactly the type of contribution I'd hope for - one that isn't for your project but could be helpful to others in lab.
On a personal note, my father-in-law was one of the trial patients who took Gleevec for his leukemia. He went into remission on it and even trialed the second and third generation Gleevec.
Apparently Gleevec binds gamma-secretase activating protein to reduce plaques caused by beta-amyloid peptide. If anyone wanted to select an aptamer against gamma-secretase activating protein, it could be functionalized with Gleevec working as a treatment for Alzheimer's disease.
I'm particularly interested in this research since my grandfather and step-grandfather suffered from Alzheimer's for a number of years prior to their passing.
Again, great job Amanda!!!
Yay for beta-amyloid! Haha, great find Amanda, good to know my research idea is not a long shot in the dark!
Post a Comment